透析装置 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の透析装置の市場規模は、2023年に744億4,000万米ドル、2030年までに988億4,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.84％の成長が見込まれます。透析装置の需要は主に、高齢化が腎機能喪失の主な危険因子となる老年人口の増加や、高血糖が腎臓の血管障害に結び付く糖尿病の有病率の増加などのさまざまな理由による、腎不全の有病率の上昇によって急増しています。さらに、高血圧も腎不全と広く関連するもう1つの大きな要因です。さらに、持続的腎代替療法（CRRT）の開発などの技術の進歩も、2024年～2030年の予測期間における透析装置市場の成長を押し上げる大きな影響要因となっています。

透析装置の市場力学

透析装置市場はさまざまな理由で勢いを増しており、主な理由の1つは慢性腎臓疾患の有病率の上昇です。これは世界の糖尿病有病率の上昇によるものと考えられます。国際糖尿病連合が『IDF Diabetes Atlas』第10版で提供したデータによると、2022年に20～79歳の5億3,700万人が世界中で糖尿病と診断されました。さらに同資料は、2030年までに糖尿病の有病率は6億4,300万人に増加すると予測しています。高血糖は糖尿病性腎臓病の発症につながり、それ自体が慢性腎臓病や末期腎臓病の重要な危険因子となります。高血糖が腎臓に多因子的な影響を及ぼすことは、多くの調査で立証されています。例えば、高血糖は腎臓に供給する血管を狭くし、腎臓のろ過能力に大きな影響を与えます。高血糖は慢性的な血行動態や代謝の変化と関連し、その結果、シグナル伝達経路、サイトカイン、転写因子、その他の因子の変化と関連します。したがって、糖尿病の有病率の上昇は、糖尿病性腎臓病や末期腎臓病などの腎臓病に関連する症例の増加と関連しており、透析処置の需要を促進し、最終的に予測期間（2024年～2030年）の透析装置市場にプラスの影響を与えます。

透析装置市場の需要を促進するもう1つの重要な側面は、老年人口の増加です。世界保健機関（WHO）が「Decade of Healthy Ageing (2020-2030) Report」で引用した数字によると、60歳以上の人口が総人口に占める割合は、2019年の10億人から2030年までに14億人と34%増加すると推定されています。同レポートはさらに、2050年までに世界の老年人口は21億人に達すると予測しています。老化に関連した構造的、分子的、機能的変化が腎臓の修復能力に影響を与え、それによって高齢者がさまざまな腎疾患に罹患しやすくなるため、老化は進行性の腎機能低下と関連しています。したがって、老年人口の増加により腎疾患の罹患率が増加し、透析需要が増加するため、今後数年間の透析装置市場の成長が促進されます。

しかし、透析処置に関連する合併症や、成長経済国における患者の透析サービスの高いコストが、透析装置市場の成長抑制要因となる可能性があります。

上記の要因に加え、透析装置市場はCOVID-19パンデミックにより収益が若干減少しました。透析は生命維持という緊急性の高い性質を持っていますが、その実施率は若干低下し、また一方でその傾向は世界中で大きく異なっていました。この特定の市場については、COVID-19パンデミックに関連する規制は、透析療法の生命維持という性質上、透析需要には影響しませんでした。しかし、パンデミック後のシナリオは、透析装置市場が最大限に活動を再開し、予測期間における透析装置市場の見通しを改善するため、透析装置市場の収益創出の好機をもたらします。

透析装置市場のセグメント分析

透析装置市場の製品セグメントでは、予測期間に持続的腎代替療法（CRRT）カテゴリがもっとも高いCAGRを記録する見込みです。これは、このタイプの透析が提供する利点に起因しています。CRRTに関連する主な利点の1つは、その他の透析法と比較して、透析中の心臓への負担が著しく減少する緩徐透析であることです。4時間ではなく24時間かけて行うため、結果的に心臓への負担が軽減されます。

当レポートでは、世界の透析装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 透析装置市場レポートのイントロダクション

第2章 透析装置市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 透析装置市場の主な要因の分析

• 透析装置市場の促進要因
  • 老年人口基盤の拡大
  • 糖尿病の有病率の増加
  • 高血圧症の有病率の上昇
  • 製品開発における技術の進歩
• 透析装置市場の抑制要因と課題
  • 手術に関連する合併症
  • 成長経済国の患者にとっての透析サービスの高いコスト
• 透析装置市場の機会
  • 製品設計の改良
  • 新興経済国における透析サービスへのアクセスの改善

第5章 透析装置市場のポーターのファイブフォース分析

第6章 透析装置市場に対するCOVID-19の影響分析

第7章 透析装置市場のレイアウト

• 製品タイプ別
  • 血液透析装置
  • 腹膜透析装置
  • 持続的腎代替療法装置
  • 消耗品
• 可動性別
  • 固定式
  • 可動式
• エンドユーザー別
  • 病院
  • 透析センター
  • 在宅ケア環境
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 透析装置市場：世界の企業シェア分析 - 主要3～5社

第9章 透析装置市場の企業と製品のプロファイル

• Fresenius Medical Care
• B. Braun Melsungen AG
• Nipro Corporation
• Dialife SA
• Baxter
• Cantel Medical Corporation
• NIKKISO CO. LTD.
• Asahi Kasei Medical
• NxStage Medical, Inc
• Infomed SA
• Medtronic
• Anjue Medical Equipment Co., Ltd
• Dialco Medical Inc
• SWS Hemodialysis Care Co., Ltd
• TORAY MEDICAL CO,.LTD
• Trivitron Healthcare
• BLT Biolight Meditech
• QUANTA Dialysis Technologies

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項と連絡先

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Dialysis Devices Market
• Table 3: Dialysis Devices Market in Global (2021-2030)
• Table 4: Dialysis Devices Market in Global by Product Type (2021-2030)
• Table 5: Dialysis Devices Market in Global by Mobility (2021-2030)
• Table 6: Dialysis Devices Market in Global by End User (2021-2030)
• Table 7: Dialysis Devices Market in Global by Geography (2021-2030)
• Table 8: Dialysis Devices Market in North America (2021-2030)
• Table 9: Dialysis Devices Market in North America by Product Type (2021-2030)
• Table 10: Dialysis Devices Market in North America by Mobility (2021-2030)
• Table 11: Dialysis Devices Market in North America by End User (2021-2030)
• Table 12: Dialysis Devices Market in North America by Country (2021-2030)
• Table 13: Dialysis Devices Market in the US (2021-2030)
• Table 14: Dialysis Devices Market in Canada (2021-2030)
• Table 15: Dialysis Devices Market in Mexico (2021-2030)
• Table 16: Dialysis Devices Market in Europe (2021-2030)
• Table 17: Dialysis Devices Market in Europe by Product Type (2021-2030)
• Table 18: Dialysis Devices Market in Europe by Mobility (2021-2030)
• Table 19: Dialysis Devices Market in Europe by End User (2021-2030)
• Table 20: Dialysis Devices Market in Europe by Country (2021-2030)
• Table 21: Dialysis Devices Market in France (2021-2030)
• Table 22: Dialysis Devices Market in Germany (2021-2030)
• Table 23: Dialysis Devices Market in the United Kingdom (2021-2030)
• Table 24: Dialysis Devices Market in Italy (2021-2030)
• Table 25: Dialysis Devices Market in Spain (2021-2030)
• Table 26: Dialysis Devices Market in Russia (2021-2030)
• Table 27: Dialysis Devices Market in Rest of Europe (2021-2030)
• Table 28: Dialysis Devices Market in APAC (2021-2030)
• Table 29: Dialysis Devices Market in APAC by Product Type (2021-2030)
• Table 30: Dialysis Devices Market in APAC by Mobility (2021-2030)
• Table 31: Dialysis Devices Market in APAC by End User (2021-2030)
• Table 32: Dialysis Devices Market in APAC by Country (2021-2030)
• Table 33: Dialysis Devices Market in China (2021-2030)
• Table 34: Dialysis Devices Market in Japan (2021-2030)
• Table 35: Dialysis Devices Market in India (2021-2030)
• Table 36: Dialysis Devices Market in Australia (2021-2030)
• Table 37: Dialysis Devices Market in South Korea (2021-2030)
• Table 38: Dialysis Devices Market in Rest of APAC (2021-2030)
• Table 39: Dialysis Devices Market in Rest of World (2021-2030)
• Table 40: Dialysis Devices Market in RoW by Product Type (2021-2030)
• Table 41: Dialysis Devices Market in RoW by Mobility (2021-2030)
• Table 42: Dialysis Devices Market in RoW by End User (2021-2030)
• Table 43: Dialysis Devices Market in RoW by Region (2021-2030)
• Table 44: Dialysis Devices Market in Middle East (2021-2030)
• Table 45: Dialysis Devices Market in Africa (2021-2030)
• Table 46: Dialysis Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Dialysis Devices Market

Figures 3: Dialysis Devices Market in Global (2021-2030)

Figures 4: Dialysis Devices Market in Global by Product Type (2021-2030)

Figures 5: Dialysis Devices Market in Global by Mobility (2021-2030)

Figures 6: Dialysis Devices Market in Global by End User (2021-2030)

Figures 7: Dialysis Devices Market in Global by Geography (2021-2030)

Figures 8: Dialysis Devices Market in North America (2021-2030)

Figures 9: Dialysis Devices Market in North America by Product Type (2021-2030)

Figures 10: Dialysis Devices Market in North America by Mobility (2021-2030)

Figures 11: Dialysis Devices Market in North America by End User (2021-2030)

Figures 12: Dialysis Devices Market in North America by Country (2021-2030)

Figures 13: Dialysis Devices Market in the US (2021-2030)

Figures 14: Dialysis Devices Market in Canada (2021-2030)

Figures 15: Dialysis Devices Market in Mexico (2021-2030)

Figures 16: Dialysis Devices Market in Europe (2021-2030)

Figures 17: Dialysis Devices Market in Europe by Product Type (2021-2030)

Figures 18: Dialysis Devices Market in Europe by Mobility (2021-2030)

Figures 19: Dialysis Devices Market in Europe by End User (2021-2030)

Figures 20: Dialysis Devices Market in Europe by Country (2021-2030)

Figures 21: Dialysis Devices Market in France (2021-2030)

Figures 22: Dialysis Devices Market in Germany (2021-2030)

Figures 23: Dialysis Devices Market in the United Kingdom (2021-2030)

Figures 24: Dialysis Devices Market in Italy (2021-2030)

Figures 25: Dialysis Devices Market in Spain (2021-2030)

Figures 26: Dialysis Devices Market in Russia (2021-2030)

Figures 27: Dialysis Devices Market in Rest of Europe (2021-2030)

Figures 28: Dialysis Devices Market in APAC (2021-2030)

Figures 29: Dialysis Devices Market in APAC by Product Type (2021-2030)

Figures 30: Dialysis Devices Market in APAC by Mobility (2021-2030)

Figures 31: Dialysis Devices Market in APAC by End User (2021-2030)

Figures 32: Dialysis Devices Market in APAC by Country (2021-2030)

Figures 33: Dialysis Devices Market in China (2021-2030)

Figures 34: Dialysis Devices Market in Japan (2021-2030)

Figures 35: Dialysis Devices Market in India (2021-2030)

Figures 36: Dialysis Devices Market in Australia (2021-2030)

Figures 37: Dialysis Devices Market in South Korea (2021-2030)

Figures 38: Dialysis Devices Market in Rest of APAC (2021-2030)

Figures 39: Dialysis Devices Market in Rest of World (2021-2030)

Figures 40: Dialysis Devices Market in RoW by Product Type (2021-2030)

Figures 41: Dialysis Devices Market in RoW by Mobility (2021-2030)

Figures 42: Dialysis Devices Market in RoW by End User (2021-2030)

Figures 43: Dialysis Devices Market in RoW by Region (2021-2030)

Figures 44: Dialysis Devices Market in Middle East (2021-2030)

Figures 45: Dialysis Devices Market in Africa (2021-2030)

Figures 46: Dialysis Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis

Dialysis Devices Market By Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines And Consumables), By Mobility (Stationary And Portable), By End User (Hospitals, Dialysis Centers, And Homecare Settings), and by geography is expected to grow at a steady CAGR (forecast period- 2024-2030) owing growing prevalence of kidney failure primarly due to increasing prevalence of diabetes and hypertension

Global dialysis devices market was valued at USD 74.44 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 98.84 billion by 2030. The demand for dialysis devices is witnessing a surge majorly due to the rising prevalence of kidney failure due to various reasons such as rising geriatric population wherein age acts as a major risk factor for loss of kidney function, rising prevalence of diabetes in which hyperglycemia is linked with blood vessel damage in kidneys. Furthermore, hypertension is another key factor which is extensively linked with kidney failure. Additionally, the technological advancements such as the development of continuous renal replacement therapy (CRRT) have also been a major influential factor in boosting the growth of the dialysis devices market during the forecast period from 2024-2030.

Dialysis Devices Market Dynamics:

The dialysis devices market is gaining momentum due to a variety of reasons with one of the key reasons being the rising prevalence of chronic kidney disorders. This can be attributed to the rising prevalence of diabetes across the globe. According to the data provided by the International Diabetes Federation in their tenth edition of the IDF Diabetes Atlas, in 2022, 537 million people in the age group of 20-79 were diagnosed with diabetes globally. The same source further predicted that by 2030, the prevalence of diabetes is expected to rise to 643 million. Hyperglycemia is linked with the development of diabetic kidney disease which in itself plays as a key risk factor for chronic kidney disease and end stage renal disease. It has been established in numerous research high blood sugar levels affect the kidneys in multifactorial ways. For instance, high blood sugar result in the narrowing of blood vessels supplying the kidney which significantly impacts the filtration capacities of the kidneys. High glycemic levels are associated with chronic hemodynamic and metabolic changes which in turn, are associated with changes in the signaling pathways, cytokines, transcription factors, and other factors. Therefore, the rising prevalence of diabetes is linked with the increasing number of cases associated with kidney diseases such as diabetic kidney disease and end stage renal disease thereby driving the demand for dialysis procedures and ultimately positively influencing the dialysis devices market during the forecast period (2024-2030).

Another important aspect driving the demand for dialysis devices market is the ascent in the geriatric population base. As per the figures cited by the World Health Organization in their Decade of Healthy Ageing (2020-2030) Report, it is estimated that people over the age of 60 years and older will account for 34% more share in the total population, from one billion in 2019 to accounting for 1.4 billion by 2030. The report further states that by 2050, the world's elderly population is expected to reach 2.1 billion. Aging is associated with progressive decline of kidney function as senescence-related structural, molecular, and functional changes affect the reparative capacity of kidney thereby predisposing older people to various renal diseases. Therefore, the growing elderly population is predicted to result in increase in incidence of renal diseases resulting in growing demand for dialysis thereby bolstering the growth of the dialysis devices market in coming years.

However, procedure-related complications and the high cost of dialysis services for patients in growing economies may be growth-restraining factors for the dialysis devices market.

Besides the above-mentioned factors, the dialysis devices market witnessed a slight dip in revenue generation due to the COVID-19 pandemic. Even though due to the urgent nature of dialysis services in terms of supporting life, there was a slight dip in conductance of such procedures however the trends across the globe varied massively. For this specific market, restrictions pertaining to the COVID-19 pandemic did not affect the demand for dialysis as such due to the life supporting nature of the therapy. However, the post-pandemic scenario provides an even opportune moment for revenue generation for the dialysis devices market due to the resumption of activities in full capacity thereby improving the market outlook for the dialysis devices market during the forecast period.

Dialysis Devices Market Segment Analysis:

Dialysis Devices Market by Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines and Consumables), by Mobility (Stationary and Portable), by End User (Hospitals, Dialysis Centers, and Homecare Settings), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the dialysis devices market, the continuous renal replacement therapy (CRRT) category is expected to register the fastest CAGR in the dialysis devices market during the forecast period. This can be attributed to the advantages offered by this type of dialysis. One of the key advantages associated with CRRT is that it is a slower type of dialysis which remarkably decreases the load on the heart during dialysis compared to other dialysis procedures. It is conducted over the period of 24 hours instead of doing it over four hours, which ultimately decreases the stress on the heart.

Additionally, compared to intermittent hemodialysis, CRRT is preferred in patients suffering from sepsis-induced acute kidney injury in removing various components such as excess metabolic waste and water, also helps in lowering pro-inflammatory cytokine levels, helps in maintaining homeostasis, lowers the negative impact on the cardiovascular system, thereby significantly improving the prognosis of the patient. Furthermore, as it has been established in various recent studies, CRRT is being preferred in COVID-19 patients with acute kidney injury as it was observed that besides helping in overcoming limitations of kidney function, it helped in ceasing the progression of severe COVID-19 infection as the CRRT therapy could remove the pro-inflammatory cytokines during the cytokine storm syndrome reported in severe COVID-19 infection.

Therefore, the demand for dialysis devices, specifically CRRT is set to register remarkable growth during the forecast period, ultimately helping the dialysis market to generate commendable revenue.

North America is expected to dominate the overall Dialysis Devices Market:

Among all the regions, North America is estimated to account for the largest share in the dialysis devices market. This domination is due to the rising prevalence of kidney disorders, rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and growing popularity of home-based dialysis devices are further expected to drive the product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural cost specifically in the United States and Canada are expected to further boost the market for dialysis devices in North America.

One of the key driving factors of the United States dialysis devices market is the interplay of various factors in the country. For instance, as per the data cited by the Centers for Disease Control and Prevention (2023), about 15% of the adults in the United States (accounting for approximately 37 million people) are estimated to have chronic kidney disease. According to further estimates presented by the source, women are slightly more affected by CKD as compared to men. CKD, over time, progresses to kidney failure thereby necessitating the need for dialysis. Therefore, the growing burden of kidney disorders indicated by the increase in patient population corresponds to the presence of a potential patient population that may require dialysis as a life supporting therapy, thus positively influencing the product demand in the nation.

Additionally, another key factor that is thought to contribute to the increasing prevalence of kidney disorders is the surge in obesity in the country population. For instance, as per the data provided by the CDC (2023), in 2017-2018, the obesity prevalence in the country was 42.4%. Obesity has been established as a formidable risk factor for the development of kidney disease. It has been studied that in patients affected by obesity, a compensatory mechanism of hyper filtration is said to take place to meet the increased metabolic demands due to gain in body weight. This can massively increase the intraglomerular pressure which may damage the kidney structure and escalate the risk of developing CKD in the long term.

Furthermore, the product development activities and product approvals by the concerned regulatory authority in North American countries are further expected to drive the product demand in the region. For instance, in March 2022, Baxter Healthcare Corporation received the regulatory approval from the US Food and Drug Administration for their AK 98 Dialysis Machine, classified as a class II medical device.

Moreover, the conducive health coverage scenario specifically in the United States and Canada also provides conditions for the regional market to grow as the coverage of procedural cost of dialysis by public and private insurers help in more people availing such services thereby contributing in the increase in access to dialysis services in the region.

Thus, the interplay of all the previously factors are likely to contribute to the market growth of dialysis devices in the United States as well as North America region as a whole during the forecast period.

Dialysis Devices Market Key Players:

Some of the key market players operating in the dialysis devices market includes Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co.,Ltd, TORAY MEDICAL CO,.LTD., Trivitron Healthcare, BLT Biolight Meditech, QUANTA Dialysis Technologies, and others.

Recent Developmental Activities in Dialysis Devices Market:

In January 2022, the US Food and Drug Administration granted the regulatory approval to Quanta Dialysis Technologies Ltd for their product- hemodialysis system SC+. The device is a portable system which is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.

In August 2020, the US FDA granted the emergency-use authorization (EUA) for REGIOCIT which is intended to be used as a replacement solution specifically in adult patients who are being treated with CRRT and for whom regional citrate anticoagulation is considered appropriate.

In October 2018, Baxter received the CE mark approval for the next-generation continuous renal replacement therapy using PrisMax system.

Key Takeaways from the Dialysis Devices Market Report Study

Market size analysis for current dialysis devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the dialysis devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global dialysis devices market.

Various opportunities available for the other competitor in the dialysis devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current dialysis devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for dialysis devices market growth in the coming future?

Target Audience who can be benefited from this Dialysis Devices Market Report Study

Dialysis devices products providers

Research organizations and consulting companies

Dialysis devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in dialysis devices

Various End-users who want to know more about the dialysis devices market and latest technological developments in the dialysis devices market.

Frequently Asked Questions for Dialysis Devices Market:

1. What is a dialysis device?

Dialysis devices are medical equipment and consumables that help in substituting for kidney function in events of kidney failure or compromised kidney function to compensate and remove toxins from the body.

2. What is the market for Global Dialysis Devices?

Global dialysis devices market was valued at USD 74.44 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 98.84 billion by 2030.

3. What are the drivers for Global Dialysis Devices Market?

The demand for dialysis devices is witnessing a surge majorly due to the rising prevalence of kidney failure due to various reasons such as rising geriatric population wherein age acts as a major risk factor for loss of kidney function, rising prevalence of diabetes in which hyperglycemia is linked with blood vessel damage in kidneys. Furthermore, hypertension is another key factor which is extensively linked with kidney failure. Additionally, the technological advancements such as the development of continuous renal replacement therapy (CRRT) have also been a major influential factor in boosting the growth of the dialysis devices market during the forecast period from 2024-2030.

4. Who are the key players operating in Global Dialysis Devices Market?

Some of the key market players operating in the dialysis devices market includes Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co.,Ltd, TORAY MEDICAL CO,.LTD., Trivitron Healthcare, BLT Biolight Meditech, QUANTA Dialysis Technologies, and others.

5. Which region has the highest share in Dialysis Devices market?

Among all the regions, North America is estimated to account for the largest share in the dialysis devices market. This domination is due to the rising prevalence of kidney disorders, rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and growing popularity of home-based dialysis devices are further expected to drive the product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural cost specifically in the United States and Canada are expected to further boost the market for dialysis devices in North America.

Table of Contents

1.Dialysis Devices Market Report Introduction

2.Dialysis Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Dialysis Devices Market Key Factors Analysis

• 4.1. Dialysis Devices Market Drivers
  • 4.1.1. Growing Geriatric Population Base
  • 4.1.2. Increasing Prevalence of Diabetes
  • 4.1.3. Rising Prevalence of Hypertension
  • 4.1.4. Technological Advancements in Product Development
• 4.2. Dialysis Devices Market Restraints and Challenges
  • 4.2.1. Procedure-Related Complications
  • 4.2.2. High Cost of Dialysis Services for Patients in Growing Economies
• 4.3. Dialysis Devices Market Opportunities
  • 4.3.1. Improving on the Product Design
  • 4.3.2. Improving Access of Dialysis Services in Emerging Economies

5. Dialysis Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Dialysis Devices Market

7. Dialysis Devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Hemodialysis Machines
  • 7.1.2. Peritoneal Dialysis Machines
  • 7.1.3. Continuous Renal Replacement Therapy Machines
  • 7.1.4. Consumables
• 7.2. By Mobility
  • 7.2.1. Stationary
  • 7.2.2. Portable
• 7.3. By End User
  • 7.3.1. Hospitals
  • 7.3.2. Dialysis Centers
  • 7.3.3. Homecare Settings
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Dialysis Devices Market, by Product Type
    • 7.4.1.2. North America Dialysis Devices Market, by Mobility
    • 7.4.1.3. North America Dialysis Devices Market, by End User
    • 7.4.1.4. North America Dialysis Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Dialysis Devices Market, by Product Type
    • 7.4.2.2. Europe Dialysis Devices Market, by Mobility
    • 7.4.2.3. Europe Dialysis Devices Market, by End User
    • 7.4.2.4. Europe Dialysis Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.2.6. Russia
    • 7.4.2.2.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Dialysis Devices Market, by Product Type
    • 7.4.3.2. Asia-Pacific Dialysis Devices Market, by Mobility
    • 7.4.3.3. Asia-Pacific Dialysis Devices Market, by End User
    • 7.4.3.4. Asia-Pacific Dialysis Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Dialysis Devices Market, by Product Type
    • 7.4.4.2. RoW Dialysis Devices Market, by Mobility
    • 7.4.4.3. RoW Dialysis Devices Market, by End User
    • 7.4.4.4. RoW Dialysis Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Dialysis Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Dialysis Devices Market Company and Product Profiles

• 9.1. Fresenius Medical Care,
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. B. Braun Melsungen AG
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Nipro Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Dialife SA
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Baxter
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Cantel Medical Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. NIKKISO CO. LTD.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Asahi Kasei Medical
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. NxStage Medical, Inc
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Infomed SA
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Medtronic
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Anjue Medical Equipment Co., Ltd
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Dialco Medical Inc
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. SWS Hemodialysis Care Co.,Ltd
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. TORAY MEDICAL CO,.LTD
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Trivitron Healthcare
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. BLT Biolight Meditech
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. QUANTA Dialysis Technologies
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us